BlackRock Health Sciences Term Trust (BMEZ) Stock Price, News & Analysis

Company Overview

BlackRock Health Sciences Trust II's (BMEZ) (the 'Trust') investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. The Trust utilizes an option writing (selling) strategy in an effort to generate current gains from options premiums and to enhance the Trust's risk-adjusted returns.

Key Stats

• Today's Range: $14.63 to $14.78
• 50-Day Range: $13.26 to $14.85
• 52-Week Range: $12.58 to $16.75
• Volume: 238,079 shs
• Average Volume: 355,042 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 15.55%
• Price Target: N/A
• Consensus Rating: N/A

BMEZ Stock Analysis - Frequently Asked Questions

How have BMEZ shares performed this year?

BlackRock Health Sciences Term Trust's stock was trading at $14.40 at the beginning of 2025. Since then, BMEZ shares have increased by 1.8% and is now trading at $14.66.
View the best growth stocks for 2025 here.

Who are BlackRock Health Sciences Term Trust's major shareholders?

Top institutional shareholders of BlackRock Health Sciences Term Trust include Royal Bank of Canada, Sit Investment Associates Inc., Invesco Ltd. and Penserra Capital Management LLC. Insiders that own company stock include Saba Capital Management, LP and Christopher Accettella.
View institutional ownership trends.

How do I buy shares of BlackRock Health Sciences Term Trust?

Shares of BMEZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BlackRock Health Sciences Term Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Health Sciences Term Trust investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Voya Infrastructure, Industrials and Materials Fund (IDE), PIMCO Dynamic Income Fund (PDI), DoubleLine Income Solutions Fund (DSL), Pimco Dynamic Income Opportunities Fund (PDO) and OneMain (OMF).

Company Calendar

• Record date for 5/30 Dividend: 5/15/2025
• Ex-Dividend for 5/30 Dividend: 5/15/2025
• Dividend Payable: 5/30/2025
• Today: 6/10/2025
• Record date for 6/30 Dividend: 6/13/2025
• Ex-Dividend for 6/30 Dividend: 6/13/2025
• Dividend Payable: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: N/A
• Industry: -
• Sub-Industry: N/A
• Current Symbol: NYSE:BMEZ
• CIK: 1785971
• Web: www.blackrock.com
• Phone: 212-810-5300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $27.54 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A